Walking can power an implantable stimulator device to speed up tendon healing

NewsGuard 100/100 Score

Researchers at CÚRAM, the SFI Research Centre for Medical Devices based at NUI Galway, have shown how the simple act of walking can power an implantable stimulator device to speed up treatment of musculoskeletal diseases.

The results of have been published in the prestigious journal Advanced Materials.

The research establishes the engineering foundations for a new range of stimulator devices that enable control of musculoskeletal tissue regeneration to treat tendon damage and disease and sports injuries, without the use of drugs or external stimulation.

One of the most exciting parts of our study is that these implantable devices may be tailored to individual patients or disorders and may show promise in accelerating the repair of sport-related tendon injuries, particularly in athletes."

Dr Manus Biggs, CÚRAM Investigator, Lead Researcher

The study investigated whether electrical therapy, coupled with exercise, would show promise in treating tendon disease or ruptures. It showed that tendon cell function and repair can be controlled through electrical stimulation from an implantable device which is powered by body movement.

Dr Marc Fernandez, who carried out the principal research of the study at CÚRAM, said: "Successful treatment of tendon damage and disease represents a critical medical challenge.

"Our discovery shows that an electrical charge is produced in the treatment target area - the damaged or injured tendon - when the implanted device is stretched during walking. The potential gamechanger here is like a power switch in a cell - the electrical stimulus turns on tendon-specific regenerative processes in the damaged tendon."

The stimulator device uses a fabric like mesh - known as a piezoelectric material - that produces electricity when stretched or put under mechanical pressure. It is made using a scaffold of nano-fibers which are one-thousandth of the thickness of a human hair

Dr Fernandez added: "We presented an implantable, electrically active device capable of controlling tendon regeneration and healing. Importantly, our research improved the therapeutic performance of the device by enhancing its structure, piezoelectric characteristics, and biological compatibility.

"We also evaluated the individual influence of mechanical, structural, and electrical cues on tendon cell function and were able to show that bioelectric cues contribute significantly in promoting tendon repair."

Dr Biggs added: "This unique strategy of combining a device which is powered through body-movement and which can induce accelerated tendon healing is expected to significantly impact the field of regenerative devices, specifically in the area of sports or trauma associated injuries.

"These devices are cost-effective, relatively easy to implant and may pave the way for a whole new class of regenerative electrical therapies."

The research was funded by Science Foundation Ireland and in particular the SFI-BBSRC Partnership programme.

Source:
Journal reference:

Fernandez-Yague, M.A., et al. (2021) A Self-Powered Piezo-Bioelectric Device Regulates Tendon Repair-Associated Signaling Pathways through Modulation of Mechanosensitive Ion Channels. Advanced Materials. doi.org/10.1002/adma.202008788.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
First-of-its-kind AI tool predicts patient response to cancer drugs at single-cell resolution